£7,862
+23%vs Oct 2024Active08717599Private limited companyLondon
MEDISON PHARMA LIMITED
Significant control: Aleksei Egorov (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Medison Pharma Limited sell?
Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
MEDISON PHARMA LIMITED is an active private limited company (company number 08717599) incorporated on 3 October 2013, registered in London. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest micro accounts cover the period ending 31 October 2025, showing net assets of £7,862, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 23% on the prior period (£6,377).
Peer position · net assets
By net assets it sits in the upper half of 143 comparable companies in London (median £100, upper quartile £10k).
02
Ownership and control
- Mr. Aleksei Egorov
- owns 75–100% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 3 October 201313 yrs ago
- Next accounts due
- 31 July 2027in 281 days
- Confirmation statement due
- 17 October 2027in 359 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- SIC 46460
- Wholesale of pharmaceutical goods
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
1
No changevs Oct 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 October 2025 | £7,862 | — | — | £45k | — | — | 1 |
| 31 October 2024 | £6,377 | — | — | £103k | — | — | 1 |
Current ratio1.17Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £7,862 at 31 October 2025
- Net assets up 10% or more on the prior period+23.3% vs prior period
- Incorporated five or more years agoIncorporated 3 October 2013
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 359 days
- Next accounts duein 281 days
- Accounts period endNet assets £7,862 · micro accounts
- Accounts period endNet assets £6,377 · micro accounts
- Incorporated
08
Similar companies in London
- EMERGENT BIOSOLUTIONS UK LTDLondon · inc. Oct 2013
- HOPE PHARMACEUTICALS, LTD.London · inc. Apr 2013
- ETMO UK LIMITEDLondon · inc. Jul 2014
- AUTOLUS LIMITEDLondon · inc. Jul 2014
- AB BIOTECHNOLOGY LIMITEDLondon · inc. Dec 2012
- 7E'S PHARMA LTDLondon · inc. Aug 2014
All companies incorporated on 3 October 2013 · in Oct 2013.
09
Reminders for MEDISON PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.